139 related articles for article (PubMed ID: 29115491)
1. Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression.
Zeng H; He Y; Yu Y; Zhang J; Zeng X; Gong F; Liu Q; Yang B
Mol Med Rep; 2018 Jan; 17(1):918-924. PubMed ID: 29115491
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol improved detrusor fibrosis induced by mast cells during progression of chronic prostatitis in rats.
He Y; Zeng H; Yu Y; Zhang J; Liu Q; Yang B
Eur J Pharmacol; 2017 Nov; 815():495-500. PubMed ID: 29031900
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis.
He Y; Zeng HZ; Yu Y; Zhang JS; Duan X; Zeng XN; Gong FT; Liu Q; Yang B
Environ Toxicol Pharmacol; 2017 Sep; 54():120-124. PubMed ID: 28704753
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol improves urinary dysfunction in rats with chronic prostatitis and suppresses the activity of the stem cell factor/c-Kit signaling pathway.
Yu Y; Jiang J; He Y; Wang W; Shen C; Yang B
Mol Med Rep; 2017 Aug; 16(2):1395-1400. PubMed ID: 29067468
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol improves smooth muscle carcinogenesis in the progression of chronic prostatitis via the downregulation of c-kit/SCF by activating Sirt1.
He Y; Zeng H; Yu Y; Zhang J; Duan X; Liu Q; Yang B
Biomed Pharmacother; 2017 Nov; 95():161-166. PubMed ID: 28841456
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Improves Cell Cycle Arrest in Chronic Prostatitis Rats, by C-kit/SCF Suppression.
He Y; Zeng H; Yu Y; Zhang J; Zeng X; Gong F; Liu Q; Yang B
DNA Cell Biol; 2017 Aug; 36(8):709-714. PubMed ID: 28604067
[TBL] [Abstract][Full Text] [Related]
7. Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.
Lin D; Zhang M; Luo C; Wei P; Cui K; Chen Z
J Immunol Res; 2022; 2022():6833867. PubMed ID: 35755168
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol Improved the Progression of Chronic Prostatitis via the Downregulation of c-kit/SCF by Activating Sirt1.
He Y; Zeng H; Yu Y; Zhang J; Zeng X; Gong F; Duan X; Liu Q; Yang B
J Agric Food Chem; 2017 Jul; 65(28):5668-5673. PubMed ID: 28648062
[TBL] [Abstract][Full Text] [Related]
9. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
Hu Y; Niu X; Wang G; Huang J; Liu M; Peng B
Andrology; 2016 Nov; 4(6):1209-1216. PubMed ID: 27565759
[TBL] [Abstract][Full Text] [Related]
10. Role of PAR2 in the Development of Lower Urinary Tract Dysfunction.
Roman K; Murphy SF; Done JD; McKenna KE; Schaeffer AJ; Thumbikat P
J Urol; 2016 Aug; 196(2):588-98. PubMed ID: 26860791
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion.
Gharaee-Kermani M; Moore BB; Macoska JA
PLoS One; 2016; 11(7):e0158357. PubMed ID: 27367854
[TBL] [Abstract][Full Text] [Related]
12. Large Accumulation of Collagen and Increased Activation of Mast Cells in Hearts of Mice with Hyperlipidemia.
Cheng Y; Zhu Y; Zhang J; Duan X; Zhang Y
Arq Bras Cardiol; 2017 Nov; 109(5):404-409. PubMed ID: 28977053
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial prostatitis and prostatic fibrosis: modern view on the treatment and prophylaxis].
Zaitsev AV; Pushkar DY; Khodyreva LA; Dudareva AA
Urologiia; 2016 Aug; (4):114-120. PubMed ID: 28247738
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways.
Zhang H; Sun Q; Xu T; Hong L; Fu R; Wu J; Ding J
Mol Med Rep; 2016 Jan; 13(1):224-30. PubMed ID: 26530037
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol efficiently improves pulmonary function via stabilizing mast cells in a rat intestinal injury model.
Huang X; Zhao W; Hu D; Han X; Wang H; Yang J; Xu Y; Li Y; Yao W; Chen C
Life Sci; 2017 Sep; 185():30-37. PubMed ID: 28733146
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
17. Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction.
Pattabiraman G; Bell-Cohn AJ; Murphy SF; Mazur DJ; Schaeffer AJ; Thumbikat P
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F466-F479. PubMed ID: 34423679
[TBL] [Abstract][Full Text] [Related]
18. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2-Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat.
Akaihata H; Matsuoka K; Hata J; Harigane Y; Yaginuma K; Endo Y; Imai H; Matsuoka Y; Onagi A; Tanji R; Honda-Takinami R; Hoshi S; Koguchi T; Sato Y; Kataoka M; Uemura M; Igawa Y; Kojima Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835398
[TBL] [Abstract][Full Text] [Related]
20. Role of the Wnt/β-catenin signaling pathway in inducing apoptosis and renal fibrosis in 5/6-nephrectomized rats.
Lin X; Zha Y; Zeng XZ; Dong R; Wang QH; Wang DT
Mol Med Rep; 2017 Jun; 15(6):3575-3582. PubMed ID: 28440442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
